Suellen Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suellen Pereira has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ana Flávia Seraine Custódio Viana
State University of Maranhão, Maranhão, Brazil
1 shared publication - Boris Timah Acha
Laboratory of Functional and Molecular Studies in Physiopharmacology, Postgraduate Program in Biotechnology, Federal University of Piauí, Teresina, Brazil
1 shared publication - Dalton Dittz
Federal University of Piaui
1 shared publication - Deyna Francélia Andrade Martins
Post Graduate Program in Pharmacology, Laboratory of Pain Pharmacology, Medicinal Plants Research Center, Federal University of Piauí—UFPI, Teresina 64049-550, Brazil
1 shared publication - Fernanda Regina Castro Almeida
Medicinal Plants Research Center, Federal University of Piauí, Avenida Nossa Senhora de Fátima s/n, Teresina 64049-550, PI, Brazil
1 shared publication - Flaviano Ribeiro Pinheiro Neto
Post Graduate Program in Pharmacology, Laboratory of Pain Pharmacology, Medicinal Plants Research Center, Federal University of Piauí—UFPI, Teresina 64049-550, Brazil
1 shared publication
Latest Publications
- Open Access
- 14 February 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (2) , 256
Anti-Hyperalgesic Effect of Isopulegol Involves GABA and NMDA Receptors in a Paclitaxel-Induced Neuropathic Pain Model
Background: Neuropathic pain can be triggered by chemotherapy drugs such as paclitaxel (PTX). Management of pain is limited by drugs’ ineffectiveness and adverse effects. Isopulegol (ISO) is a monoterpene present in the essential oils of several aromatic plants and has promising pharmacological activities. Objectives: to evaluate the antinociceptive activity of ISO in a PTX-induced neuropathic pain model. Methods: the toxicity of ISO was evaluated in healthy and cancerous cells. Behavioral assessments were performed using the von Frey and acetone tests. We investigated the involvement of the GABAergic pathway, NMDA, TNF-α, and the release of GABA and glutamate in the presence of ISO. Results: ISO showed little or no cytotoxicity in U87 and MDA-MB-231 cells. In both acute and subacute treatment, ISO at doses of 25, 50, and 100 mg/kg (* p < 0.05) increased the mechanical nociceptive threshold of neuropathic animals compared to the control group and reduced thermal sensitivity. Its action was reversed by pre-treatment with flumazenil and potentiated by the NMDA antagonist, MK-801. TNF-α and glutamate levels were reduced and GABA release was increased in the tests carried out. Conclusions: ISO shows low toxicity in neuronal cells and its association with PTX generated synergism in its cytotoxic action. The antinociceptive effect of ISO is due to activation of GABA and antagonism of NMDA receptors and involves the stabilization of neuronal plasma membranes leading to an imbalance in the release of neurotransmitters, favoring GABA-mediated inhibition over glutamatergic excitation.
- 14 February 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (2) , 256
Open AccessAnti-Hyperalgesic Effect of Isopulegol Involves GABA and NMDA Receptors in a Paclitaxel-Induced Neuropathic Pain Model
Background: Neuropathic pain can be triggered by chemotherapy drugs such as paclitaxel (PTX). Management of pain is limited by drugs’ ineffectiveness and adverse effects. Isopulegol (ISO) is a monoterpene present in the essential oils of several aromatic plants and has promising pharmacological activities. Objectives: to evaluate the antinociceptive activity of ISO in a PTX-induced neuropathic pain model. Methods: the toxicity of ISO was evaluated in healthy and cancerous cells. Behavioral assessments were performed using the von Frey and acetone tests. We investigated the involvement of the GABAergic pathway, NMDA, TNF-α, and the release of GABA and glutamate in the presence of ISO. Results: ISO showed little or no cytotoxicity in U87 and MDA-MB-231 cells. In both acute and subacute treatment, ISO at doses of 25, 50, and 100 mg/kg (* p < 0.05) increased the mechanical nociceptive threshold of neuropathic animals compared to the control group and reduced thermal sensitivity. Its action was reversed by pre-treatment with flumazenil and potentiated by the NMDA antagonist, MK-801. TNF-α and glutamate levels were reduced and GABA release was increased in the tests carried out. Conclusions: ISO shows low toxicity in neuronal cells and its association with PTX generated synergism in its cytotoxic action. The antinociceptive effect of ISO is due to activation of GABA and antagonism of NMDA receptors and involves the stabilization of neuronal plasma membranes leading to an imbalance in the release of neurotransmitters, favoring GABA-mediated inhibition over glutamatergic excitation.